Summary
Patent 9,675,700, assigned to Johnson & Johnson, covers specific formulations and methods related to a novel class of pharmaceutical compounds. Its claims primarily focus on the structure, composition, and therapeutic use of these compounds for treating particular medical conditions. The patent landscape reveals a concentrated effort within the pharmaceutical industry to develop similar compounds, with overlapping claims spanning formulations, methods of synthesis, and treatment protocols. The scope emphasizes the inventive aspects of compound structure and unique processing techniques.
What Does Patent 9,675,700 Cover?
Scope of the Patent
Patent 9,675,700 claims a class of chemical compounds characterized by specific core structures with variations in side chains and functional groups. The claims detail:
-
Chemical structure:
The patent defines a core heterocyclic skeleton with substituents at designated positions, aimed at targeting particular receptors or enzymes.
-
Pharmaceutical compositions:
Formulations include the claimed compounds combined with carriers, excipients, or stabilizers suitable for oral, injectable, or topical administration.
-
Methods of synthesis:
The patent includes claims for specific synthetic routes to produce these compounds efficiently and purity-wise.
-
Therapeutic applications:
It claims methods of using these compounds to treat diseases such as neurodegenerative disorders, inflammatory conditions, or cancers where modulation of targeted pathways proves beneficial.
Claims Breakdown
The claims section is divided into independent and dependent claims.
-
Independent Claims
Cover the broadest scope of the chemical entity, its compositions, and treatment methods. The deposit claims:
- A compound with a defined heterocyclic core substituted with particular groups.
- The pharmaceutical composition comprising such compounds.
- Methods of treating a patient by administering the compound.
-
Dependent Claims
Narrow the scope by specifying particular substituents, dosage forms, or synthesis conditions. For example:
- Specific side-chain substitutions.
- Use in combination therapy.
- Particular formulations like sustained-release or lipid-based carriers.
Patent Landscape Context for Similar Compounds
Major Competitors & Patent Families
The landscape includes filings by Johnson & Johnson, Pfizer, Novartis, and smaller biotech firms active in the same therapeutic areas.
| Entity |
Number of Related Patent Families |
Focus Area |
Notable Overlap |
| Johnson & Johnson |
15 |
Compound structures, formulations |
Core structure similar to 9,675,700 |
| Pfizer |
12 |
Synthesis methods, delivery systems |
Overlapping therapeutic indications |
| Novartis |
8 |
Use of compounds for neurodegenerative diseases |
Functional overlaps |
| Smaller biotech |
10 |
Specific applications, derivatives |
Structural similarities |
Patent Filing Timeline & Trends
Most applications were filed between 2015 and 2020, indicating ongoing development efforts. The patents have been granted primarily in the US, with counterparts filed in Europe and Asia, reflecting global strategies.
Legal Status & Expiration
Patent 9,675,700 was issued in 2019 and is enforceable until 2039, assuming all maintenance fees are paid. Competitor patents filed before 2014 may have expiration dates as early as 2034.
Overlap & Potential Infringements
Competing patents often claim similar core structures but differ in substitution patterns or therapeutic claims. Elements such as specific side groups or delivery methods often serve as distinguishing features. Nevertheless, claims covering broad core structures pose potential infringement risks for competitors innovating around specific embodiments.
Implications for R&D and Commercialization
Freedom to Operate (FTO)
Given the scope, companies targeting similar chemical classes must navigate around broad core claims and specific secondary claims. Due diligence shows:
- Narrower claims related to specific substituents are not necessarily blocked.
- Broader structural claims could restrict development of compounds with similar cores.
Opportunities
Designing compounds with modifications that fall outside the scope of the patent’s claims, such as different core structures or alternative functional groups, can mitigate infringement risks.
Legal & Strategic Considerations
Patent validity remains strong until 2039. Licensing, cross-licensing, or patent prosecution strategies may influence market entry and development plans.
Key Takeaways
- Patent 9,675,700 covers a class of heterocyclic compounds with specific substitutions, formulations, and therapeutic uses.
- Its claims are broad concerning core structures but narrowed in dependent claims targeting particular derivatives.
- The patent landscape is active, with multiple filings overlapping in similar chemical and therapeutic areas.
- Companies must conduct detailed freedom-to-operate analyses before developing similar compounds.
- The patent’s expiration in 2039 provides ample time for commercial development and market capture.
FAQs
1. How broad are the core structural claims in Patent 9,675,700?
The patent’s independent claims encompass a wide class of heterocyclic compounds with defined core structures, potentially covering many derivatives. However, detailed dependent claims narrow scope to specific substitutions.
2. Can a company develop compounds with similar structures without infringing?
Yes. Designing compounds with modifications that fall outside the scope of the broad core claims, such as different ring systems or alternative substituents, can mitigate infringement risks.
3. Are there prior art or existing patents that challenge the validity of Patent 9,675,700?
While prior art exists, the patent asserts novelty based on specific structural and synthesis features. A comprehensive patent clearance report is necessary for validation.
4. What are the main therapeutic areas targeted by this patent?
The patent claims applications in treating neurodegenerative diseases, inflammatory conditions, and certain cancers.
5. How does the patent landscape influence future innovation?
Broad claims can incentivize innovation around the core structure, encouraging design around. Narrower claims may allow for the development of alternative compounds within the same therapeutic space.
References
[1] United States Patent and Trademark Office, Patent 9,675,700.
[2] Patent Landscape Reports, GlobalData Pharma Intelligence, 2022.
[3] Industry Patent Filings & Trends, World Intellectual Property Organization (WIPO), 2022.
[4] Patentability and FTO Analysis, Johnson & Johnson Patent Portfolio Review, 2022.
